Mavacamten

Mavacamten

Mavacamtenis a cardiac myosin inhibitor

Systematic name

6-[[(1S)-1-phenylethyl]amino]-3-propan-2-yl-1H-pyrimidine-2,4-dione

Brand name(s)

Camzyos

Therapeutic category

Used to treat obstructive  hypertrophic cardiomyopathy

Available formulations

Solid

Approvals

U/Development

Do you have
a question?
lets Have
a Talk

Nuraychemicals is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2012 by a team with vast experience across the pharmaceutical value chain, the company is on a mission to become the most preferred partner for pharmaceuticals.